Minimally Invasive Treatment Methods for Pilonidal Disease
NCT ID: NCT03070028
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2017-01-01
2020-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Platelet-rich Plasma in Pilonidal Sinus Disease
NCT04697082
Crystallized Phenol Versus Transposition Flaps for Treatment of Pilonidal Disease: A Prospective Study
NCT01792557
Nonoperative Treatment of Recurrent Pilonidal Sinus Disease
NCT04423510
Phenol or Laser: Best Minimally Invasive Treatment for Pilonidal Sinus?
NCT06721169
Effect of Platelet Rich Plasma (PRP) on Healing Time in Patients Following Pilonidal Sinus Surgery
NCT06206330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phenol
crystallised phenol application
crystallised phenol
crystallised phenol will be applied to sinus cavity
platelet rich plasma
PRP application
Platelet rich plasma
platelet rich plasma will be applied to sinus cavity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
crystallised phenol
crystallised phenol will be applied to sinus cavity
Platelet rich plasma
platelet rich plasma will be applied to sinus cavity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* accepting to be involved in the study
Exclusion Criteria
* having connective tissue disorders
* diabetes mellitus
* severe anemia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uşak University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barış Sevinç
assistant proffessor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barış Sevinç, M.D.
Role: PRINCIPAL_INVESTIGATOR
Uşak University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uşak University
Uşak, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sevinc B, Damburaci N, Karahan O. Comparison of Curettage Plus Platelet-Rich Plasma Gel and Curettage Plus Phenol Application in Treatment of Pilonidal Sinus Disease: A Randomized Trial. Dis Colon Rectum. 2022 May 1;65(5):735-741. doi: 10.1097/DCR.0000000000002082.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.